AyoOluwa O. Olubamiwa
Role not yet determined Is this you? Add your title
Also affiliated: United States Food and Drug Administration (2024–2025)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
AyoOluwa O. Olubamiwa's research centers on understanding drug-induced liver injury (DILI), with a specific focus on the role of drug interactions with UDP-glucuronosyltransferase (UGT) enzymes. Olubamiwa has contributed to updated databases, such as DILIrank 2.0, which aims to predict DILI risk by analyzing FDA labeling and literature reviews. The researcher also investigates the broader roles of drug-metabolizing enzymes and transporters in the development of DILI. Collaborations within the National Center for Toxicological Research include shared publications with Minjun Chen, Tsung‐Jen Liao, and Skylar Connor. Olubamiwa's work is supported by publications in peer-reviewed journals, with a recent output in 2025.
Metrics
- h-index: 3
- Publications: 3
- Citations: 24
Selected Publications
-
DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review (2025)
-
Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury (2024)
Collaboration Network
Top Collaborators
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
- DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
Similar Researchers
Based on overlapping research topics